Clinical Trial Site

El Paso, Texas 79935

2 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, ER Positive Breast Cancer, Elevated Urinary Oxalate Levels, HER2 Negative Breast Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Recurrent Calcium Oxalate Kidney Stone Disease

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels — Stopped early